Results 171 to 180 of about 4,368 (201)

Finerenone in diabetic kidney disease: A systematic review and critical appraisal

Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2022
Anoop Misra, Awadhesh Kumar Singh, Akriti Singh   +2 more
exaly  

Cardiovascular Events with Finerenone in CKD and Diabetes

New England Journal of Medicine, 2022
Alberto, Ortiz, Pantelis, Sarafidis, Charles J, Ferro   +2 more
openaire   +5 more sources

Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial

Circulation, 2022
Bertram Pitt, Rajiv Agarwal, Peter Rossing   +2 more
exaly  

Effect of finerenone on diabetic kidney disease outcomes with estimated glomerular filtration rate below 25 mL/min/1.73 m

Metabolism Open, 2023
Akira Mima, Shinji Lee, Ami Murakami
exaly  

Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)

Nephrology Dialysis Transplantation, 2023
Rajiv Agarwal, Peter Rossing, Hiddo J L Heerspink   +2 more
exaly  

Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

European Heart Journal - Cardiovascular Pharmacotherapy, 2023
Bertram Pitt, Peter Rossing, Gerasimos Filippatos   +2 more
exaly  

Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial

Diabetes, Obesity and Metabolism, 2022
Bertram Pitt, Luis Miguel Ruilope, Rajiv Agarwal   +2 more
exaly  

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

European Heart Journal, 2022
Bertram Pitt, Luis Miguel Ruilope, Rajiv Agarwal   +2 more
exaly  

Finerenone in chronic kidney disease

Nature Reviews Nephrology, 2020
openaire   +2 more sources

A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes

Kidney International, 2023
Amer Joseph, Robert Lawatscheck, Christiane Ahlers   +2 more
exaly